Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001
-
Shares outstanding
-
303M
-
Number of holders
-
200
-
Total 13F shares, excl. options
-
170M
-
Shares change
-
+27.1M
-
Total reported value, excl. options
-
$4.41B
-
Value change
-
+$829M
-
Put/Call ratio
-
1.03
-
Number of buys
-
124
-
Number of sells
-
-88
-
Price
-
$25.94
Significant Holders of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) as of Q4 2020
254 filings reported holding PACB - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 as of Q4 2020.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) has 200 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 170M shares
of 303M outstanding shares and own 56.21% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (28.5M shares), BlackRock Inc. (15.1M shares), VANGUARD GROUP INC (14.3M shares), Jackson Square Partners, LLC (13.5M shares), Capital International Investors (9.81M shares), SB Management Ltd (9.19M shares), Capital World Investors (5.45M shares), Nikko Asset Management Americas, Inc. (5.02M shares), Casdin Capital, LLC (5M shares), and Sumitomo Mitsui Trust Holdings, Inc. (4.48M shares).
This table shows the top 200 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.